Biostatistician at Unlearn AI

San Francisco, California, United States

Apply Now

$150,000 – $180,000Compensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, Technology, Artificial IntelligenceIndustries

Requirements

At least 2 years of experience at a pharmaceutical/biotech company or CRO supporting clinical trials
MS or PhD in Statistics or Biostatistics
Experience writing statistical analysis plans and collaboration (inferred from context)

Responsibilities

Define statistical analyses to utilize digital twins to improve the power and lower the sample size requirements of RCTs and to provide a comparator for single arm trials
Carry out internal and external case studies to utilize ML-based predictions in clinical trial applications
Work with customers in trial planning applications to use digital twins to select and optimize inclusion/exclusion criteria, endpoints, and simulate trial outcomes
Author regulatory documents such as SAP and protocol sections or briefing book contributions for clinical trials that use digital twins
Present to clients and prospective clients on statistical methodology using digital twins and results of analyses, and represent Unlearn to the broader scientific community
Collaborate with internal teams to develop evidence and test methodologies

Skills

Key technologies and capabilities for this role

BiostatisticsMachine LearningGenerative AIClinical TrialsStatistical ModelingPatient Outcome ForecastingDigital Twins

Questions & Answers

Common questions about this position

What is the salary range for the Biostatistician position?

The salary range is $150K - $180K.

Is this a remote position or does it require working in an office?

This information is not specified in the job description.

What skills are required for the Biostatistician role?

Biostatisticians need practical experience in clinical trial design and analysis, expertise in state-of-the-art ML approaches including PROCOVA, Bayesian or single-arm analyses, and the determination and autonomy to own projects end-to-end.

What is the company culture like at Unlearn AI?

Unlearners are ambitious, disciplined experimenters, gritty, receptive to new ideas, storytellers, and team-oriented, prioritizing the mission first, company second, team third, and individuals last.

What makes a strong candidate for this Biostatistician role?

Strong candidates have practical experience in clinical trials, the determination and autonomy to own projects end-to-end, and a eagerness to collaborate with an excellent and diverse team.

Unlearn AI

Creates AI-driven digital twins for healthcare

About Unlearn AI

Unlearn.AI creates digital twins of patients using artificial intelligence, which are virtual replicas that simulate potential health outcomes. This technology allows healthcare providers to predict how a patient's health may change over time, leading to more informed treatment decisions. The primary clients include healthcare providers and pharmaceutical companies, who can use these digital twins in clinical trials to simulate control groups, potentially speeding up drug development and approval processes. Unlearn.AI differentiates itself by offering a unique simulation technology that reduces the need for actual human control groups, which can save time and resources. The company's goal is to enhance decision-making in patient care and drug development through precise health outcome predictions.

San Francisco, CaliforniaHeadquarters

2017Year Founded

$127.1MTotal Funding

SERIES_CCompany Stage

AI & Machine Learning, HealthcareIndustries

51-200Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Unlimited Paid Time Off

Paid Holidays

Commuter Benefits

Paid Parental Leave

Company Equity

Risks

Over-reliance on AI data may lead to inaccuracies in trial outcomes.

Increased competition from companies like Consilx and Aicure could impact market share.

High clinical trial failure rates could affect perception of Unlearn AI's effectiveness.

Differentiation

Unlearn AI's TwinRCT uses digital twins to enhance clinical trial precision.

The company offers TrialPioneer, a free tool for innovative trial design exploration.

Unlearn AI's digital twin technology reduces the need for human control groups.

Upsides

AI in clinical trials market expected to reach $2.74 billion by 2030.

Partnership with ProJenX highlights AI's potential in specific therapeutic areas.

TwinRCT 3.0 enhances decision-making in Phase II trials for better outcomes.

Land your dream remote job 3x faster with AI

Try Jobo Free